Cargando…
Activity of ceftolozane-tazobactam and comparators against gram-negative bacilli: Results from the study for monitoring antimicrobial resistance trends (SMART – Brazil; 2016–2017)
Multi-drug resistant Gram-negative bacilli (GNB) have been reported as cause of serious hospital-acquired infections worldwide. The aim of this study was to investigate the in vitro activity of ceftolozane-tazobactam compared to other agents against GNB isolated from patients admitted to Brazilian m...
Autores principales: | Beirão, Elisa Maria, Rodrigues, Suellen da Silva, Andrade, Tarik Klain de, Serra, Fernando Brandão, Paula, Marina Della Negra de, Polis, Thales Jose Bueno, Gales, Ana Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392090/ https://www.ncbi.nlm.nih.gov/pubmed/32663440 http://dx.doi.org/10.1016/j.bjid.2020.05.010 |
Ejemplares similares
-
841. Frequency of carbapenemase-encoding genes among Imipenem-Resistant Gram-negative Bacilli isolated from Latin America: Is there a Role for Imipenem/Relebactam? Results from SMART 2017-2018
por: Gales, Ana Cristina, et al.
Publicado: (2020) -
Evaluation of in vitro activity of ceftolozane–tazobactam against recent clinical bacterial isolates from Brazil – the EM200 study
por: Tuon, Felipe Francisco, et al.
Publicado: (2020) -
1698. Activity of ceftolozane/tazobactam in vitro against Gram-negative isolates from pediatric patients: SMART 2017-2021
por: Mu, Xinli, et al.
Publicado: (2023) -
In vitro activity of ceftazidime–avibactam, ceftolozane–tazobactam, and other comparable agents against clinically important Gram-negative bacilli: results from the 2017 Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART)
por: Jean, Shio-Shin, et al.
Publicado: (2018) -
Ceftolozane-tazobactam in nosocomial pneumonia
por: Candel, Francisco Javier, et al.
Publicado: (2022)